WO2025098457 - ACYLATED INSULIN FOR REDUCING BLOOD GLUCOSE
National phase entry is expected:
Publication Number
WO/2025/098457
Publication Date
15.05.2025
International Application No.
PCT/CN2024/130670
International Filing Date
07.11.2024
Title **
[English]
ACYLATED INSULIN FOR REDUCING BLOOD GLUCOSE
[French]
INSULINE ACYLÉE POUR RÉDUIRE LA GLYCÉMIE
[Chinese]
用于降糖的酰化胰岛素
Applicants **
GAN & LEE PHARM CO LTD
Inventors
GAN, Zhongru
CHEN, Wei
ZHAO, Jing
HAO, Chunyue
Priority Data
202311472986.8
07.11.2023
CN
202410702372.2
02.06.2024
CN
202411087070.5
08.08.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2179 | |
| EPO | Filing, Examination, Granting | 16480 | |
| Japan | Filing, Examination, Granting | 2449 | |
| South Korea | Filing, Examination, Granting | 2677 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
29,125
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to acylated insulin for reducing blood glucose. Provided is a method for treating or preventing metabolic syndrome and type II diabetes in a subject in need thereof by administering a compound of formula (I) or a pharmaceutically acceptable salt thereof. Further provided is a kit comprising an instruction for treatment according to the method.[French]
La présente invention concerne une insuline acylée pour réduire la glycémie. L'invention concerne une méthode de traitement ou de prévention du syndrome métabolique et du diabète de type II chez un sujet en ayant besoin par l'administration d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne en outre un kit comprenant une instruction de traitement selon la méthode.[Chinese]
涉及用于降糖的酰化胰岛素，提供一种通过施用式(I)化合物或其药学上可接受的盐治疗或预防有需要的受试者代谢综合征以及II型糖尿病的方法。还提供包含根据所述方法进行治疗的说明书的药盒。